πŸ‡ΊπŸ‡Έ FDA
Patent

US 9682925

Cyclopropaneamine compound

granted A61KA61K31/167A61K31/36

Quick answer

US patent 9682925 (Cyclopropaneamine compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/167, A61K31/36, A61K31/366, A61K31/381